NEW YORK (Reuters Health) – Recombinant factor VIIa (rFVIIa) appears to be safe and effective when used for off-label indications in pediatric patients, according to a report from…
NEW YORK (Reuters Health) – Compared to white light cystoscopy, hexaminolevulinate fluorescence cystoscopic detection of papillary, nonmuscle invasive bladder cancer appears superior, researchers report in a May 12th…
NEW YORK (Reuters Health) – Endobronchial ultrasound-guided transbronchial needle aspiration (EBUS-TBNA) is a good first test in patients with isolated mediastinal lymphadenopathy (IML), one that might spare many…
NEW YORK (Reuters Health) – Infliximab for inflammatory bowel disease (IBD) is not associated with an increased risk for serious infection, death, or malignancy, including lymphoma, according to…
NEW YORK (Reuters Health) – The antiarrhythmic dronedarone (Multag, Sanofi SA) should be used with caution, particularly in patients with cardiovascular risk factors, advise clinicians in a report…
NEW YORK (Reuters Health) – Anemia of prematurity is associated with poor feeding and weight gain. A new study finds that correcting AOP with packed red blood cell…
NEW YORK (Reuters Health) – In real-world patients with diffuse large B-cell lymphoma (DLBCL), the most common subtype of non-Hodgkin lymphoma (NHL), adding rituximab to first-line chemotherapy improves…
NEW YORK (Reuters Health) – In a large population-based cohort from Italy, aspirin therapy for primary prevention of cardiovascular events was associated with a significantly increased risk of…
NEW YORK (Reuters Health) – Generally, the accuracy of antigen-based point-of-care tests for hepatitis B infection is high, but the sensitivity of antibody-based tests needs to be improved,…
NEW YORK (Reuters Health) – Reperfusion-induced myocardial edema during percutaneous coronary intervention for MI can be attenuated by applying ischemic conditioning at the start of reperfusion, a French…